These letters have become the stuff of investing legend; a frank, funny, unflinching, and honest review of his past year’s performance and a clear-eyed outlook for the year ahead.
These cannabis firms can be like “catalysts” for big gains across a cannabis portfolio, because, as legal cannabis sales in the United States climb toward $45 billion by 2025, these companies stand to reap the bulk of that revenue.
Europe was a “mere” $359 million market in 2020, but Executive Chair Boris Jordan and CEO Joseph Bayern believe Europe could ultimately prove to be a $120 billion cannabis market.
Over the next decade in the United States, walking into a cannabis dispensary to buy a pack of pre-rolled joints will be just as commonplace as it is right now to go into a liquor store and buy a six-pack of beer.
That will cut out the cost of grow operations, and it will also allow the company to focus more on its branding to stand out from the crowd.
Cannabis ETF has seen impressive returns of nearly 13% year to date, whereas the S&P 500, in this exceptionally good year, is less than a percentage point higher.
Now, as I mentioned earlier, Curaleaf is just one of the Buffett-style “jewels” in the National Institute for Cannabis Investors’ model portfolio.
Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions.
Any reproduction, copying, or redistribution , of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.